Cargando…
COVID-19: potential therapeutics for pediatric patients
The global spread of COVID-19 has imparted significant economic, medical, and social burdens. Like adults, children are affected by this pandemic. However, milder clinical symptoms are often experienced by them. Only a minimal proportion of the affected patients may develop severe and complicated CO...
Autores principales: | Younis, Nour K., Zareef, Rana O., Fakhri, Ghina, Bitar, Fadi, Eid, Ali H., Arabi, Mariam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8403523/ https://www.ncbi.nlm.nih.gov/pubmed/34458951 http://dx.doi.org/10.1007/s43440-021-00316-1 |
Ejemplares similares
-
Cardiac Manifestations in COVID-19 Patients: A Focus on the Pediatric Population
por: Abi Nassif, Tania, et al.
Publicado: (2021) -
COVID-19 in Pediatric Patients: A Focus on CHD Patients
por: Zareef, Rana O., et al.
Publicado: (2020) -
Hydroxychloroquine in COVID-19 Patients: Pros and Cons
por: Younis, Nour K., et al.
Publicado: (2020) -
Pathogenesis and distribution of infective endocarditis in the pediatric population: a 20-year experience in a tertiary care center in a developing country
por: Rashed, Moustafa, et al.
Publicado: (2023) -
Aspirin in COVID-19: Pros and Cons
por: Zareef, Rana, et al.
Publicado: (2022)